[ad_1]
By Ernie Mundell and Robin Foster HealthDay Reporters
Long-time meteorologist and morning TV co-host Al Roker said Friday that he has prostate cancer and will have surgery next week to have his prostate removed.
The 66-year-old made the announcement on NBC’s “Today,” and said he hopes to be back on the show in about two weeks, CBS News reported.
“It’s a good news-bad news kind of thing,” Roker said. “Good news is we caught it early. Not great news is that it’s a little aggressive, so I’m going to be taking some time off to take care of this.”
Roker’s surgery will be performed at Memorial Sloan Kettering Cancer Center in New York City, and will be conducted by Dr. Vincent Laudone, who spoke about Roker’s diagnosis on “Today” on Friday, CBS News reported.
“Fortunately, his cancer appears somewhat limited or confined to the prostate, but because it’s more aggressive, we wanted to treat it, and after discussion regarding all of the different options — surgery, radiation, focal therapy — we settled on removing the prostate,” Laudone said.
Copyright © 2020 HealthDay. All rights reserved.
IMAGES
Prostate Illustrion
Browse through our medical image collection to see illustrations of human anatomy and physiology
See Images
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
